Article History
Received: 22 December 2022
Accepted: 21 May 2024
First Online: 19 June 2024
Declarations
:
: This article is a review piece and no ethical committee approvals were required for the completion of the manuscript.
: GA has no conflict of interest. TJB has filed patents in anti-MAP therapy and JMA has developed and has patents in mycobacterial culture media for CWDM, some of which were used to obtain the photomicrographs which accompany this article.